CoChat
Cited by 248

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Properties and Functions of Fibroblasts and Myofibroblasts in Myocardial Infarction

Open access
Venugopal, Harikrishnan, Hanna, Anis, Humeres, Claudio, Frangogiannis, Nikolaos G. · 2022 · Cells

Abstract

The adult mammalian heart contains abundant interstitial and perivascular fibroblasts that expand following injury and play a reparative role but also contribute to maladaptive fibrotic remodeling. Following myocardial infarction, cardiac fibroblasts undergo dynamic phenotypic transitions, contributing to the regulation of inflammatory, reparative, and angiogenic responses. This review manuscript discusses the mechanisms of regulation, roles and fate of fibroblasts in the infarcted heart. During the inflammatory phase of infarct healing, the release of alarmins by necrotic cells promotes a pro-inflammatory and matrix-degrading fibroblast phenotype that may contribute to leukocyte recruitment. The clearance of dead cells and matrix debris from the infarct stimulates anti-inflammatory pathways and activates transforming growth factor (TGF)-β cascades, resulting in the conversion of fibroblasts to α-smooth muscle actin (α-SMA)-expressing myofibroblasts. Activated myofibroblasts secrete large amounts of matrix proteins and form a collagen-based scar that protects the infarcted ventricle from catastrophic complications, such as cardiac rupture. Moreover, infarct fibroblasts may also contribute to cardiac repair by stimulating angiogenesis. During scar maturation, fibroblasts disassemble α-SMA+ stress fibers and convert to specialized cells that may serve in scar maintenance. The prolonged activation of fibroblasts and myofibroblasts in the infarct border zone and in the remote remodeling myocardium may contribute to adverse remodeling and to the pathogenesis of heart failure. In addition to their phenotypic plasticity, fibroblasts exhibit remarkable heterogeneity. Subsets with distinct phenotypic profiles may be responsible for the wide range of functions of fibroblast populations in infarcted and remodeling hearts.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cells11091386

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Research works printed but not linked: 187

  1. Frangogiannis, 2015, Pathophysiology of Myocardial Infarction, Compr. Physiol., 5, 1841, 10.1002/cphy.c150006 · DOI · Paper page
  2. Humeres, 2019, Fibroblasts in the Infarcted, Remodeling, and Failing Heart, JACC Basic Transl. Sci., 4, 449, 10.1016/j.jacbts.2019.02.006 · DOI · Paper page
  3. Burke, 2021, Fibroblast contributions to ischemic cardiac remodeling, Cell Signal., 77, 109824, 10.1016/j.cellsig.2020.109824 · DOI
  4. Hanna, 2020, Validation of diagnostic criteria and histopathological characterization of cardiac rupture in the mouse model of nonreperfused myocardial infarction, Am. J. Physiol. Heart Circ. Physiol., 319, H948, 10.1152/ajpheart.00318.2020 · DOI
  5. Humeres, 2022, Smad7 effects on TGF-beta and ErbB2 restrain myofibroblast activation and protect from postinfarction heart failure, J. Clin. Investig., 132, e146926, 10.1172/JCI146926 · DOI
  6. Ivey, 2016, Defining the Cardiac Fibroblast, Circ. J., 80, 2269, 10.1253/circj.CJ-16-1003 · DOI · Paper page
  7. Buechler, 2021, Cross-tissue organization of the fibroblast lineage, Nature, 593, 575, 10.1038/s41586-021-03549-5 · DOI · Paper page
  8. Muhl, 2020, Single-cell analysis uncovers fibroblast heterogeneity and criteria for fibroblast and mural cell identification and discrimination, Nat. Commun., 11, 3953, 10.1038/s41467-020-17740-1 · DOI · Paper page
  9. Tallquist, 2020, Cardiac Fibroblast Diversity, Annu. Rev. Physiol., 82, 63, 10.1146/annurev-physiol-021119-034527 · DOI · Paper page
  10. Zak, 1974, Development and proliferative capacity of cardiac muscle cells, Circ. Res., 35, 17
  11. Nag, 1980, Study of non-muscle cells of the adult mammalian heart: A fine structural analysis and distribution, Cytobios, 28, 41
  12. Banerjee, 2007, Determination of cell types and numbers during cardiac development in the neonatal and adult rat and mouse, Am. J. Physiol. Heart Circ. Physiol., 293, H1883, 10.1152/ajpheart.00514.2007 · DOI · Paper page
  13. Camelliti, 2004, Fibroblast network in rabbit sinoatrial node: Structural and functional identification of homogeneous and heterogeneous cell coupling, Circ. Res., 94, 828, 10.1161/01.RES.0000122382.19400.14 · DOI · Paper page
  14. Franke, 1979, Intermediate-sized filaments of human endothelial cells, J. Cell Biol., 81, 570, 10.1083/jcb.81.3.570 · DOI · Paper page
  15. Gabbiani, 1981, Vascular smooth muscle cells differ from other smooth muscle cells: Predominance of vimentin filaments and a specific alpha-type actin, Proc. Natl. Acad. Sci. USA, 78, 298, 10.1073/pnas.78.1.298 · DOI · Paper page
  16. Desmouliere, 1993, Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts, J. Cell Biol., 122, 103, 10.1083/jcb.122.1.103 · DOI · Paper page
  17. Dixon, 2019, Periostin Reexpression in Heart Disease Contributes to Cardiac Interstitial Remodeling by Supporting the Cardiac Myofibroblast Phenotype, Adv. Exp. Med. Biol., 1132, 35, 10.1007/978-981-13-6657-4_4 · DOI
  18. Kong, 2013, Lack of specificity of fibroblast-specific protein 1 in cardiac remodeling and fibrosis, Am. J. Physiol. Heart Circ. Physiol., 305, H1363, 10.1152/ajpheart.00395.2013 · DOI · Paper page
  19. Schneider, 2007, S100A4 is upregulated in injured myocardium and promotes growth and survival of cardiac myocytes, Cardiovasc. Res., 75, 40, 10.1016/j.cardiores.2007.03.027 · DOI
  20. Chen, 2012, Dynamic regulation of platelet-derived growth factor receptor alpha expression in alveolar fibroblasts during realveolarization, Am. J. Respir. Cell Mol. Biol., 47, 517, 10.1165/rcmb.2012-0030OC · DOI
  21. Alex, 2022, Validation of Specific and Reliable Genetic Tools to Identify, Label, and Target Cardiac Pericytes in Mice, J. Am. Heart Assoc., 11, e023171, 10.1161/JAHA.121.023171 · DOI
  22. Ieda, 2009, Cardiac fibroblasts regulate myocardial proliferation through beta1 integrin signaling, Dev. Cell, 16, 233, 10.1016/j.devcel.2008.12.007 · DOI · Paper page
  23. Ivey, 2019, Platelet-derived growth factor receptor-alpha is essential for cardiac fibroblast survival, Am. J. Physiol. Heart Circ. Physiol., 317, H330, 10.1152/ajpheart.00054.2019 · DOI
  24. Huang, 2020, The role of Smad2 and Smad3 in regulating homeostatic functions of fibroblasts in vitro and in adult mice, Biochim. Biophys. Acta Mol. Cell Res., 1867, 118703, 10.1016/j.bbamcr.2020.118703 · DOI
  25. Nicin, 2021, Fibroblast-mediated intercellular crosstalk in the healthy and diseased heart, FEBS Lett., 10, e019338
  26. Weber, 1989, Cardiac interstitium in health and disease: The fibrillar collagen network, J. Am. Coll. Cardiol., 13, 1637, 10.1016/0735-1097(89)90360-4 · DOI · Paper page
  27. Kohl, 2005, Electrical coupling of fibroblasts and myocytes: Relevance for cardiac propagation, J. Electrocardiol., 38, 45, 10.1016/j.jelectrocard.2005.06.096 · DOI · Paper page
  28. Gaudesius, 2003, Coupling of cardiac electrical activity over extended distances by fibroblasts of cardiac origin, Circ. Res., 93, 421, 10.1161/01.RES.0000089258.40661.0C · DOI · Paper page
  29. Xiao, 2019, Hippo pathway deletion in adult resting cardiac fibroblasts initiates a cell state transition with spontaneous and self-sustaining fibrosis, Genes Dev., 33, 1491, 10.1101/gad.329763.119 · DOI
  30. Khalil, 2019, Cell-specific ablation of Hsp47 defines the collagen-producing cells in the injured heart, JCI Insight, 4, e128722, 10.1172/jci.insight.128722 · DOI
  31. Reichardt, 2021, Controlling cardiac fibrosis through fibroblast state space modulation, Cell. Signal., 79, 109888, 10.1016/j.cellsig.2020.109888 · DOI
  32. Shinde, 2014, Fibroblasts in myocardial infarction: A role in inflammation and repair, J. Mol. Cell. Cardiol., 70C, 74, 10.1016/j.yjmcc.2013.11.015 · DOI · Paper page
  33. Saxena, 2013, IL-1 Induces Proinflammatory Leukocyte Infiltration and Regulates Fibroblast Phenotype in the Infarcted Myocardium, J. Immunol., 191, 4838, 10.4049/jimmunol.1300725 · DOI · Paper page
  34. Frangogiannis, 2000, Myofibroblasts in reperfused myocardial infarcts express the embryonic form of smooth muscle myosin heavy chain (SMemb), Cardiovasc. Res., 48, 89, 10.1016/S0008-6363(00)00158-9 · DOI · Paper page
  35. Cleutjens, 1995, Collagen remodeling after myocardial infarction in the rat heart, Am. J. Pathol., 147, 325
  36. Turner, 2009, Interleukin-1alpha stimulates proinflammatory cytokine expression in human cardiac myofibroblasts, Am. J. Physiol. Heart Circ. Physiol., 297, H1117, 10.1152/ajpheart.00372.2009 · DOI
  37. Mitchell, 2007, IL-1beta stimulates rat cardiac fibroblast migration via MAP kinase pathways, Am. J. Physiol. Heart Circ. Physiol., 292, H1139, 10.1152/ajpheart.00881.2005 · DOI
  38. Boza, 2016, Expression and function of toll-like receptor 4 and inflammasomes in cardiac fibroblasts and myofibroblasts: IL-1beta synthesis, secretion, and degradation, Mol. Immunol., 74, 96, 10.1016/j.molimm.2016.05.001 · DOI
  39. Lugrin, 2015, Cutting Edge: IL-1alpha Is a Crucial Danger Signal Triggering Acute Myocardial Inflammation during Myocardial Infarction, J. Immunol., 194, 499, 10.4049/jimmunol.1401948 · DOI
  40. Frangogiannis, 1998, Resident cardiac mast cells degranulate and release preformed TNF-alpha, initiating the cytokine cascade in experimental canine myocardial ischemia/reperfusion, Circulation, 98, 699, 10.1161/01.CIR.98.7.699 · DOI · Paper page
  41. Kumar, 1997, Induction of monocyte chemoattractant protein-1 in the small veins of the ischemic and reperfused canine myocardium, Circulation, 95, 693, 10.1161/01.CIR.95.3.693 · doi:10.1161/01.cir.95.3.693
  42. Gwechenberger, 1999, Cardiac myocytes produce interleukin-6 in culture and in viable border zone of reperfused infarctions, Circulation, 99, 546, 10.1161/01.CIR.99.4.546 · DOI · Paper page
  43. Sandanger, 2013, The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia-reperfusion injury, Cardiovasc. Res., 99, 164, 10.1093/cvr/cvt091 · DOI · Paper page
  44. Anzai, 2017, The infarcted myocardium solicits GM-CSF for the detrimental oversupply of inflammatory leukocytes, J. Exp. Med., 214, 3293, 10.1084/jem.20170689 · DOI · Paper page
  45. Gao, 2015, Matrix metalloproteinase 9 secreted by hypoxia cardiac fibroblasts triggers cardiac stem cell migration in vitro, Stem. Cells Int., 2015, 836390, 10.1155/2015/836390 · doi:10.1155/2015/836390
  46. Awad, 2010, Tumor necrosis factor induces matrix metalloproteinases in cardiomyocytes and cardiofibroblasts differentially via superoxide production in a PI3Kgamma-dependent manner, Am. J. Physiol. Cell Physiol., 298, C679, 10.1152/ajpcell.00351.2009 · DOI
  47. Hanna, 2021, Collagen denaturation in the infarcted myocardium involves temporally distinct effects of MT1-MMP-dependent proteolysis and mechanical tension, Matrix Biol., 99, 18, 10.1016/j.matbio.2021.05.005 · DOI
  48. Konstantinidis, 2012, Mechanisms of cell death in heart disease, Arter. Thromb. Vasc. Biol., 32, 1552, 10.1161/ATVBAHA.111.224915 · DOI · Paper page
  49. Jennings, 1990, Development of cell injury in sustained acute ischemia, Circulation, 82, II2
  50. Reimer, 1977, The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs, Circulation, 56, 786, 10.1161/01.CIR.56.5.786 · DOI · Paper page
  51. Mayorga, 2004, Bcl-2 is a key factor for cardiac fibroblast resistance to programmed cell death, J. Biol. Chem., 279, 34882, 10.1074/jbc.M404616200 · DOI
  52. Abrial, 2014, Cardiac fibroblasts protect cardiomyocytes against lethal ischemia-reperfusion injury, J. Mol. Cell. Cardiol., 68, 56, 10.1016/j.yjmcc.2014.01.005 · DOI
  53. Wan, 2013, Enhanced efferocytosis of apoptotic cardiomyocytes through myeloid-epithelial-reproductive tyrosine kinase links acute inflammation resolution to cardiac repair after infarction, Circ. Res., 113, 1004, 10.1161/CIRCRESAHA.113.301198 · DOI · Paper page
  54. Chen, 2019, Macrophage Smad3 Protects the Infarcted Heart, Stimulating Phagocytosis and Regulating Inflammation, Circ. Res., 125, 55, 10.1161/CIRCRESAHA.119.315069 · DOI · Paper page
  55. Hofmann, 2015, Role of lymphocytes in myocardial injury, healing, and remodeling after myocardial infarction, Circ. Res., 116, 354, 10.1161/CIRCRESAHA.116.304072 · DOI · Paper page
  56. Nakaya, 2017, Cardiac myofibroblast engulfment of dead cells facilitates recovery after myocardial infarction, J. Clin. Investig., 127, 383, 10.1172/JCI83822 · DOI
  57. Willems, 1994, The alpha-smooth muscle actin-positive cells in healing human myocardial scars, Am. J. Pathol., 145, 868
  58. Aisagbonhi, 2011, Experimental myocardial infarction triggers canonical Wnt signaling and endothelial-to-mesenchymal transition, Dis. Model Mech., 4, 469, 10.1242/dmm.006510 · DOI · Paper page
  59. Haider, 2019, Transition of Macrophages to Fibroblast-Like Cells in Healing Myocardial Infarction, J. Am. Coll. Cardiol., 74, 3124, 10.1016/j.jacc.2019.10.036 · DOI · Paper page
  60. Mollmann, 2006, Bone marrow-derived cells contribute to infarct remodelling, Cardiovasc. Res., 71, 661, 10.1016/j.cardiores.2006.06.013 · DOI · Paper page
  61. Kanisicak, 2016, Genetic lineage tracing defines myofibroblast origin and function in the injured heart, Nat. Commun., 7, 12260, 10.1038/ncomms12260 · DOI · Paper page
  62. Cattaneo, 2018, Infarct Fibroblasts Do Not Derive From Bone Marrow Lineages, Circ. Res., 122, 583, 10.1161/CIRCRESAHA.117.311490 · DOI
  63. Blankesteijn, 1997, A homologue of Drosophila tissue polarity gene frizzled is expressed in migrating myofibroblasts in the infarcted rat heart, Nat. Med., 3, 541, 10.1038/nm0597-541 · DOI
  64. Shinde, 2017, The role of alpha-smooth muscle actin in fibroblast-mediated matrix contraction and remodeling, Biochim. Biophys. Acta, 1863, 298, 10.1016/j.bbadis.2016.11.006 · DOI · Paper page
  65. Detillieux, 2003, Biological activities of fibroblast growth factor-2 in the adult myocardium, Cardiovasc. Res., 57, 8, 10.1016/S0008-6363(02)00708-3 · DOI · Paper page
  66. Stawowy, 2004, Regulation of matrix metalloproteinase MT1-MMP/MMP-2 in cardiac fibroblasts by TGF-beta1 involves furin-convertase, Cardiovasc. Res., 63, 87, 10.1016/j.cardiores.2004.03.010 · DOI
  67. Freed, 2011, Role of myosin light chain kinase in cardiotrophin-1-induced cardiac myofibroblast cell migration, Am. J. Physiol. Heart Circ. Physiol., 301, H514, 10.1152/ajpheart.01041.2010 · DOI
  68. Manso, 2009, Integrins, focal adhesions, and cardiac fibroblasts, J. Investig. Med., 57, 856, 10.2310/JIM.0b013e3181c5e61f · DOI
  69. 2001, The de-adhesive activity of matricellular proteins: Is intermediate cell adhesion an adaptive state?, J. Clin. Investig., 107, 785, 10.1172/JCI12609 · DOI · Paper page
  70. Ghersi, 2002, Regulation of fibroblast migration on collagenous matrix by a cell surface peptidase complex, J. Biol. Chem., 277, 29231, 10.1074/jbc.M202770200 · DOI · Paper page
  71. Shinde, 2017, Mechanisms of Fibroblast Activation in the Remodeling Myocardium, Curr. Pathobiol. Rep., 5, 145, 10.1007/s40139-017-0132-z · DOI
  72. Gibb, 2020, Myofibroblasts and Fibrosis: Mitochondrial and Metabolic Control of Cellular Differentiation, Circ. Res., 127, 427, 10.1161/CIRCRESAHA.120.316958 · DOI · Paper page
  73. Ma, F., Li, Y., Jia, L., Han, Y., Cheng, J., Li, H., Qi, Y., and Du, J. (2012). Macrophage-stimulated cardiac fibroblast production of IL-6 is essential for TGF beta/Smad activation and cardiac fibrosis induced by angiotensin II. PLoS ONE, 7. · DOI · Paper page
  74. Kobayashi, 2014, Matrix metalloproteinase-9 activates TGF-beta and stimulates fibroblast contraction of collagen gels, Am. J. Physiol. Lung Cell. Mol. Physiol., 306, L1006, 10.1152/ajplung.00015.2014 · DOI · Paper page
  75. Gurantz, 1999, Tumor necrosis factor-alpha upregulates angiotensin II type 1 receptors on cardiac fibroblasts, Circ. Res., 85, 272, 10.1161/01.RES.85.3.272 · DOI
  76. Maqbool, 2013, Interleukin-1 has opposing effects on connective tissue growth factor and tenascin-C expression in human cardiac fibroblasts, Matrix Biol., 32, 208, 10.1016/j.matbio.2013.02.003 · DOI
  77. Tamaoki, 2005, Tenascin-C regulates recruitment of myofibroblasts during tissue repair after myocardial injury, Am. J. Pathol., 167, 71, 10.1016/S0002-9440(10)62954-9 · DOI · Paper page
  78. Bageghni, 2019, Fibroblast-specific deletion of interleukin-1 receptor-1 reduces adverse cardiac remodeling following myocardial infarction, JCI Insight, 5, e125074, 10.1172/jci.insight.125074 · DOI
  79. Melendez, 2010, Interleukin 6 mediates myocardial fibrosis, concentric hypertrophy, and diastolic dysfunction in rats, Hypertension, 56, 225, 10.1161/HYPERTENSIONAHA.109.148635 · DOI · Paper page
  80. Muller, 2014, Interleukin-6-dependent phenotypic modulation of cardiac fibroblasts after acute myocardial infarction, Basic Res. Cardiol., 109, 440, 10.1007/s00395-014-0440-y · DOI
  81. Wang, 2016, Hypoxia-stimulated cardiac fibroblast production of IL-6 promotes myocardial fibrosis via the TGF-β1 signaling pathway, Lab. Investig., 96, 839, 10.1038/labinvest.2016.65 · DOI
  82. Chou, 2018, IL-6 trans-signalling contributes to aldosterone-induced cardiac fibrosis, Cardiovasc. Res., 114, 690, 10.1093/cvr/cvy013 · DOI
  83. Fredj, 2005, Interactions between cardiac cells enhance cardiomyocyte hypertrophy and increase fibroblast proliferation, J. Cell. Physiol., 202, 891, 10.1002/jcp.20197 · DOI
  84. Banerjee, 2009, IL-6 loss causes ventricular dysfunction, fibrosis, reduced capillary density, and dramatically alters the cell populations of the developing and adult heart, Am. J. Physiol. Heart Circ. Physiol., 296, H1694, 10.1152/ajpheart.00908.2008 · DOI
  85. Brown, 2007, Cytokines regulate matrix metalloproteinases and migration in cardiac fibroblasts, Biochem. Biophys. Res. Commun., 362, 200, 10.1016/j.bbrc.2007.08.003 · DOI
  86. Siwik, 2000, Interleukin-1beta and tumor necrosis factor-alpha decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro, Circ. Res., 86, 1259, 10.1161/01.RES.86.12.1259 · DOI · Paper page
  87. Bujak, 2008, Interleukin-1 receptor type I signaling critically regulates infarct healing and cardiac remodeling, Am. J. Pathol., 173, 57, 10.2353/ajpath.2008.070974 · DOI · Paper page
  88. Gurantz, 2005, IL-1beta and TNF-alpha upregulate angiotensin II type 1 (AT1) receptors on cardiac fibroblasts and are associated with increased AT1 density in the post-MI heart, J. Mol. Cell. Cardiol., 38, 505, 10.1016/j.yjmcc.2004.12.015 · DOI
  89. Turner, 2010, Modulatory effect of interleukin-1α on expression of structural matrix proteins, MMPs and TIMPs in human cardiac myofibroblasts: Role of p38 MAP kinase, Matrix Biol., 29, 613, 10.1016/j.matbio.2010.06.007 · DOI
  90. Turner, 2011, Human cardiac fibroblasts express ICAM-1, E-selectin and CXC chemokines in response to proinflammatory cytokine stimulation, Int. J. Biochem. Cell Biol., 43, 1450, 10.1016/j.biocel.2011.06.008 · DOI
  91. Bräuninger, H., Thottakara, T., Schön, J., Voss, S., Dhople, V., Warnke, S., Scherschel, K., Schrage, B., Kirchhof, P., and Blankenberg, S. (2021). Cytokine-Mediated Alterations of Human Cardiac Fibroblast’s Secretome. Int. J. Mol. Sci., 22. · DOI
  92. Shi, 2018, S100A8/A9 promotes MMP-9 expression in the fibroblasts from cardiac rupture after myocardial infarction by inducing macrophages secreting TNFα, Eur. Rev. Med. Pharmacol. Sci., 22, 3925
  93. He, 2011, A physiological concentration of glucocorticoid inhibits the pro-inflammatory cytokine-induced proliferation of adult rat cardiac fibroblasts: Roles of extracellular signal-regulated kinase 1/2 and nuclear factor-κB, Clin. Exp. Pharmacol. Physiol., 38, 739, 10.1111/j.1440-1681.2011.05581.x · DOI
  94. Frangogiannis, N.G. (2022). Transforming growth factor-beta in myocardial disease. Nat. Rev. Cardiol., ahead of print. · DOI · Paper page
  95. Dewald, 2004, Of mice and dogs: Species-specific differences in the inflammatory response following myocardial infarction, Am. J. Pathol., 164, 665, 10.1016/S0002-9440(10)63154-9 · DOI · Paper page
  96. Frangogiannis, 2005, The critical role of endogenous Thrombospondin (TSP)-1 in preventing expansion of healing myocardial infarcts, Circulation, 111, 2935, 10.1161/CIRCULATIONAHA.104.510354 · DOI · Paper page
  97. Sarrazy, 2014, Integrins alphavbeta5 and alphavbeta3 promote latent TGF-beta1 activation by human cardiac fibroblast contraction, Cardiovasc. Res., 102, 407, 10.1093/cvr/cvu053 · DOI · Paper page
  98. Frangogiannis, 2020, Transforming Growth Factor (TGF)-beta in tissue fibrosis, J. Exp. Med., 217, e20190103, 10.1084/jem.20190103 · DOI · Paper page
  99. Kong, 2018, Opposing Actions of Fibroblast and Cardiomyocyte Smad3 Signaling in the Infarcted Myocardium, Circulation, 137, 707, 10.1161/CIRCULATIONAHA.117.029622 · DOI · Paper page
  100. Bugg, 2020, Infarct Collagen Topography Regulates Fibroblast Fate via p38-Yes-Associated Protein Transcriptional Enhanced Associate Domain Signals, Circ. Res., 127, 1306, 10.1161/CIRCRESAHA.119.316162 · DOI
  101. Huang, 2019, Distinct roles of myofibroblast-specific Smad2 and Smad3 signaling in repair and remodeling of the infarcted heart, J. Mol. Cell. Cardiol., 132, 84, 10.1016/j.yjmcc.2019.05.006 · DOI
  102. Hanna, 2019, The Role of the TGF-beta Superfamily in Myocardial Infarction, Front. Cardiovasc. Med., 6, 140, 10.3389/fcvm.2019.00140 · DOI · Paper page
  103. House, 2005, Cardioprotection induced by cardiac-specific overexpression of fibroblast growth factor-2 is mediated by the MAPK cascade, Am. J. Physiol. Heart Circ. Physiol., 289, H2167, 10.1152/ajpheart.00392.2005 · DOI
  104. Virag, 2007, Fibroblast growth factor-2 regulates myocardial infarct repair: Effects on cell proliferation, scar contraction, and ventricular function, Am. J. Pathol., 171, 1431, 10.2353/ajpath.2007.070003 · DOI · Paper page
  105. Zymek, 2006, The role of platelet-derived growth factor signaling in healing myocardial infarcts, J. Am. Coll. Cardiol., 48, 2315, 10.1016/j.jacc.2006.07.060 · DOI · Paper page
  106. Simm, 1998, Mitogenic effect of PDGF-AA on cardiac fibroblasts, Basic Res. Cardiol., 93, 40, 10.1007/s003950050209 · DOI
  107. Saraswati, 2020, Small proline-rich repeat 3 is a novel coordinator of PDGFRbeta and integrin beta1 crosstalk to augment proliferation and matrix synthesis by cardiac fibroblasts, FASEB J., 34, 7885, 10.1096/fj.201902815R · DOI
  108. Weber, 2012, Myofibroblast-mediated mechanisms of pathological remodelling of the heart, Nat. Rev. Cardiol., 10, 15, 10.1038/nrcardio.2012.158 · DOI · Paper page
  109. Zeigler, 2020, Computational model predicts paracrine and intracellular drivers of fibroblast phenotype after myocardial infarction, Matrix Biol., 91–92, 136, 10.1016/j.matbio.2020.03.007 · DOI
  110. Kagami, 1994, Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells, J. Clin. Investig., 93, 2431, 10.1172/JCI117251 · DOI · Paper page
  111. Campbell, 1997, Angiotensin II stimulated expression of transforming growth factor-beta1 in cardiac fibroblasts and myofibroblasts, J. Mol. Cell. Cardiol., 29, 1947, 10.1006/jmcc.1997.0435 · DOI · Paper page
  112. Schorb, 1993, Angiotensin II is mitogenic in neonatal rat cardiac fibroblasts, Circ. Res., 72, 1245, 10.1161/01.RES.72.6.1245 · DOI · Paper page
  113. Sadoshima, 1993, Molecular characterization of angiotensin II--induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype, Circ. Res., 73, 413, 10.1161/01.RES.73.3.413 · DOI · Paper page
  114. Crabos, 1994, Characterization of angiotensin II receptors in cultured adult rat cardiac fibroblasts. Coupling to signaling systems and gene expression, J. Clin. Investig., 93, 2372, 10.1172/JCI117243 · DOI · Paper page
  115. Thibault, 2001, Upregulation of alpha(8)beta(1)-integrin in cardiac fibroblast by angiotensin II and transforming growth factor-beta1, Am. J. Physiol. Cell Physiol., 281, C1457, 10.1152/ajpcell.2001.281.5.C1457 · doi:10.1152/ajpcell.2001.281.5.c1457
  116. Lijnen, 2006, Angiotensin II-stimulated collagen production in cardiac fibroblasts is mediated by reactive oxygen species, J. Hypertens., 24, 757, 10.1097/01.hjh.0000217860.04994.54 · DOI
  117. Ohkubo, 1997, Angiotensin type 2 receptors are reexpressed by cardiac fibroblasts from failing myopathic hamster hearts and inhibit cell growth and fibrillar collagen metabolism, Circulation, 96, 3954, 10.1161/01.CIR.96.11.3954 · DOI · Paper page
  118. Kurisu, 2003, Cardiac angiotensin II type 2 receptor activates the kinin/NO system and inhibits fibrosis, Hypertension, 41, 99, 10.1161/01.HYP.0000050101.90932.14 · DOI · Paper page
  119. Schieffer, 1994, Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat, Circulation, 89, 2273, 10.1161/01.CIR.89.5.2273 · DOI · Paper page
  120. Lijnen, 2000, Induction of cardiac fibrosis by aldosterone, J. Mol. Cell. Cardiol., 32, 865, 10.1006/jmcc.2000.1129 · DOI · Paper page
  121. Bonnard, 2022, Roles of Mineralocorticoid Receptors in Cardiovascular and Cardiorenal Diseases, Annu. Rev. Physiol., 84, 585, 10.1146/annurev-physiol-060821-013950 · DOI
  122. Neumann, 2002, Aldosterone and D-glucose stimulate the proliferation of human cardiac myofibroblasts in vitro, Hypertension, 39, 756, 10.1161/hy0302.105295 · DOI
  123. Brilla, 1994, Collagen metabolism in cultured adult rat cardiac fibroblasts: Response to angiotensin II and aldosterone, J. Mol. Cell. Cardiol., 26, 809, 10.1006/jmcc.1994.1098 · DOI · Paper page
  124. Rickard, 2009, Deletion of mineralocorticoid receptors from macrophages protects against deoxycorticosterone/salt-induced cardiac fibrosis and increased blood pressure, Hypertension, 54, 537, 10.1161/HYPERTENSIONAHA.109.131110 · DOI · Paper page
  125. Li, 2017, Mineralocorticoid Receptor Deficiency in T Cells Attenuates Pressure Overload-Induced Cardiac Hypertrophy and Dysfunction Through Modulating T-Cell Activation, Hypertension, 70, 137, 10.1161/HYPERTENSIONAHA.117.09070 · DOI
  126. Rickard, 2012, Cardiomyocyte mineralocorticoid receptors are essential for deoxycorticosterone/salt-mediated inflammation and cardiac fibrosis, Hypertension, 60, 1443, 10.1161/HYPERTENSIONAHA.112.203158 · DOI
  127. Isobe, 2009, Molecular imaging for efficacy of pharmacologic intervention in myocardial remodeling, JACC Cardiovasc. Imaging, 2, 187, 10.1016/j.jcmg.2008.11.011 · DOI
  128. Hayashi, 2003, Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a marker of myocardial collagen synthesis in patients with first anterior acute myocardial infarction, Circulation, 107, 2559, 10.1161/01.CIR.0000068340.96506.0F · DOI · Paper page
  129. Kim, 2002, Beta-adrenergic receptor-mediated DNA synthesis in cardiac fibroblasts is dependent on transactivation of the epidermal growth factor receptor and subsequent activation of extracellular signal-regulated kinases, J. Biol. Chem., 277, 32116, 10.1074/jbc.M204895200 · DOI
  130. Turner, 2003, Chronic beta2-adrenergic receptor stimulation increases proliferation of human cardiac fibroblasts via an autocrine mechanism, Cardiovasc. Res., 57, 784, 10.1016/S0008-6363(02)00729-0 · DOI
  131. Molkentin, 2017, Fibroblast-Specific Genetic Manipulation of p38 Mitogen-Activated Protein Kinase In Vivo Reveals Its Central Regulatory Role in Fibrosis, Circulation, 136, 549, 10.1161/CIRCULATIONAHA.116.026238 · DOI · Paper page
  132. Frangogiannis, 2020, Extracellular Matrix in Ischemic Heart Disease, Part 4/4: JACC Focus Seminar, J. Am. Coll. Cardiol., 75, 2219, 10.1016/j.jacc.2020.03.020 · DOI
  133. Dugina, 2001, Focal adhesion features during myofibroblastic differentiation are controlled by intracellular and extracellular factors, J. Cell Sci., 114, 3285, 10.1242/jcs.114.18.3285 · DOI · Paper page
  134. Kohan, 2010, EDA-containing cellular fibronectin induces fibroblast differentiation through binding to alpha4beta7 integrin receptor and MAPK/Erk 1/2-dependent signaling, FASEB J., 24, 4503, 10.1096/fj.10-154435 · DOI · Paper page
  135. Arslan, 2011, Lack of fibronectin-EDA promotes survival and prevents adverse remodeling and heart function deterioration after myocardial infarction, Circ. Res., 108, 582, 10.1161/CIRCRESAHA.110.224428 · DOI · Paper page
  136. Lenga, 2008, Osteopontin expression is required for myofibroblast differentiation, Circ. Res., 102, 319, 10.1161/CIRCRESAHA.107.160408 · DOI · Paper page
  137. Schellings, 2009, Absence of SPARC results in increased cardiac rupture and dysfunction after acute myocardial infarction, J. Exp. Med., 206, 113, 10.1084/jem.20081244 · DOI · Paper page
  138. Oka, 2007, Genetic manipulation of periostin expression reveals a role in cardiac hypertrophy and ventricular remodeling, Circ. Res., 101, 313, 10.1161/CIRCRESAHA.107.149047 · DOI · Paper page
  139. Voss, 2015, Osteoglycin prevents cardiac dilatation and dysfunction after myocardial infarction through infarct collagen strengthening, Circ. Res., 116, 425, 10.1161/CIRCRESAHA.116.304599 · DOI
  140. Zhang, 2021, Matricellular Protein Cilp1 Promotes Myocardial Fibrosis in Response to Myocardial Infarction, Circ. Res., 129, 1021, 10.1161/CIRCRESAHA.121.319482 · DOI
  141. Suto, 2018, Thrombospondin-1 regulation of latent TGF-beta activation: A therapeutic target for fibrotic disease, Matrix Biol., 68–69, 28
  142. Shimazaki, 2008, Periostin is essential for cardiac healing after acute myocardial infarction, J. Exp. Med., 205, 295, 10.1084/jem.20071297 · DOI · Paper page
  143. Bein, 2000, Thrombospondin type 1 repeats interact with matrix metalloproteinase 2. Regulation of metalloproteinase activity, J. Biol. Chem., 275, 32167, 10.1074/jbc.M003834200 · DOI · Paper page
  144. Roche, 2015, Intracellular signaling of cardiac fibroblasts, Compr. Physiol., 5, 721, 10.1002/cphy.c140044 · DOI
  145. Sinfield, 2013, p38 MAPK alpha mediates cytokine-induced IL-6 and MMP-3 expression in human cardiac fibroblasts, Biochem. Biophys. Res. Commun., 430, 419, 10.1016/j.bbrc.2012.11.071 · DOI
  146. Bageghni, 2018, Cardiac fibroblast-specific p38alpha MAP kinase promotes cardiac hypertrophy via a putative paracrine interleukin-6 signaling mechanism, FASEB J., 32, 4941, 10.1096/fj.201701455RR · DOI
  147. Lighthouse, 2016, Transcriptional control of cardiac fibroblast plasticity, J. Mol. Cell. Cardiol., 91, 52, 10.1016/j.yjmcc.2015.12.016 · DOI
  148. Loirand, 2013, Small G proteins in the cardiovascular system: Physiological and pathological aspects, Physiol. Rev., 93, 1659, 10.1152/physrev.00021.2012 · DOI
  149. Phrommintikul, 2008, Effects of a Rho kinase inhibitor on pressure overload induced cardiac hypertrophy and associated diastolic dysfunction, Am. J. Physiol. Heart Circ. Physiol., 294, H1804, 10.1152/ajpheart.01078.2007 · DOI
  150. Shimizu, 2017, Fibroblast deletion of ROCK2 attenuates cardiac hypertrophy, fibrosis, and diastolic dysfunction, JCI Insight, 2, e93187, 10.1172/jci.insight.93187 · DOI
  151. Mia, M.M., Cibi, D.M., Binte Abdul Ghani, S.A., Singh, A., Tee, N., Sivakumar, V., Bogireddi, H., Cook, S.A., Mao, J., and Singh, M.K. (2021). Loss of Yap/taz in cardiac fibroblasts attenuates adverse remodeling and improves cardiac function. Cardiovasc. Res., cvab205. · DOI
  152. Francisco, 2020, Blockade of Fibroblast YAP Attenuates Cardiac Fibrosis and Dysfunction Through MRTF-A Inhibition, JACC Basic Transl. Sci., 5, 931, 10.1016/j.jacbts.2020.07.009 · DOI · Paper page
  153. Lal, 2014, Cardiac fibroblast glycogen synthase kinase-3β regulates ventricular remodeling and dysfunction in ischemic heart, Circulation, 130, 419, 10.1161/CIRCULATIONAHA.113.008364 · DOI · Paper page
  154. Travers, 2017, Pharmacological and Activated Fibroblast Targeting of Gβγ-GRK2 After Myocardial Ischemia Attenuates Heart Failure Progression, J. Am. Coll. Cardiol., 70, 958, 10.1016/j.jacc.2017.06.049 · DOI
  155. Snider, 2021, Targeting 5-HT(2B) Receptor Signaling Prevents Border Zone Expansion and Improves Microstructural Remodeling After Myocardial Infarction, Circulation, 143, 1317, 10.1161/CIRCULATIONAHA.120.051517 · DOI
  156. Scharf, 2019, Inactivation of Sox9 in fibroblasts reduces cardiac fibrosis and inflammation, JCI Insight, 5, e126721, 10.1172/jci.insight.126721 · DOI
  157. Dufeys, 2021, AMPKalpha1 deletion in myofibroblasts exacerbates post-myocardial infarction fibrosis by a connexin 43 mechanism, Basic Res. Cardiol., 116, 10, 10.1007/s00395-021-00846-y · DOI
  158. Davis, 2015, MBNL1-mediated regulation of differentiation RNAs promotes myofibroblast transformation and the fibrotic response, Nat. Commun., 6, 10084, 10.1038/ncomms10084 · DOI
  159. Potter, 2018, Inhibiting Fibronectin Attenuates Fibrosis and Improves Cardiac Function in a Model of Heart Failure, Circulation, 138, 1236, 10.1161/CIRCULATIONAHA.118.034609 · DOI · Paper page
  160. Wu, 2021, Angiogenesis after acute myocardial infarction, Cardiovasc. Res., 117, 1257, 10.1093/cvr/cvaa287 · DOI · Paper page
  161. Mouton, 2019, Fibroblast polarization over the myocardial infarction time continuum shifts roles from inflammation to angiogenesis, Basic Res. Cardiol., 114, 6, 10.1007/s00395-019-0715-4 · DOI · Paper page
  162. Saraswati, 2019, Identification of a pro-angiogenic functional role for FSP1-positive fibroblast subtype in wound healing, Nat. Commun., 10, 3027, 10.1038/s41467-019-10965-9 · DOI
  163. Ubil, 2014, Mesenchymal-endothelial transition contributes to cardiac neovascularization, Nature, 514, 585, 10.1038/nature13839 · DOI · Paper page
  164. Meng, 2020, Reservoir of Fibroblasts Promotes Recovery From Limb Ischemia, Circulation, 142, 1647, 10.1161/CIRCULATIONAHA.120.046872 · DOI
  165. Zhang, 2017, SOX17 Regulates Conversion of Human Fibroblasts Into Endothelial Cells and Erythroblasts by Dedifferentiation Into CD34(+) Progenitor Cells, Circulation, 135, 2505, 10.1161/CIRCULATIONAHA.116.025722 · DOI
  166. He, 2017, Preexisting endothelial cells mediate cardiac neovascularization after injury, J. Clin. Investig., 127, 2968, 10.1172/JCI93868 · DOI · Paper page
  167. Hanyu, 2001, The N domain of Smad7 is essential for specific inhibition of transforming growth factor-beta signaling, J. Cell Biol., 155, 1017, 10.1083/jcb.200106023 · DOI · Paper page
  168. Hayashi, 1997, The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling, Cell, 89, 1165, 10.1016/S0092-8674(00)80303-7 · DOI · Paper page
  169. Ebisawa, 2001, Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation, J. Biol. Chem., 276, 12477, 10.1074/jbc.C100008200 · DOI · Paper page
  170. Cunnington, 2011, Antifibrotic properties of c-Ski and its regulation of cardiac myofibroblast phenotype and contractility, Am. J. Physiol. Cell Physiol., 300, C176, 10.1152/ajpcell.00050.2010 · DOI
  171. Landry, 2021, SKI activates the Hippo pathway via LIMD1 to inhibit cardiac fibroblast activation, Basic Res. Cardiol., 116, 25, 10.1007/s00395-021-00865-9 · DOI
  172. Yokota, 2020, Type V Collagen in Scar Tissue Regulates the Size of Scar after Heart Injury, Cell, 182, 545, 10.1016/j.cell.2020.06.030 · DOI · Paper page
  173. Krstevski, 2020, New perspectives of the cardiac cellular landscape: Mapping cellular mediators of cardiac fibrosis using single-cell transcriptomics, Biochem. Soc. Trans., 48, 2483, 10.1042/BST20191255 · DOI
  174. Farbehi, 2019, Single-cell expression profiling reveals dynamic flux of cardiac stromal, vascular and immune cells in health and injury, eLife, 8, e43882, 10.7554/eLife.43882 · DOI · Paper page
  175. Pyagay, 2005, Collagen triple helix repeat containing 1, a novel secreted protein in injured and diseased arteries, inhibits collagen expression and promotes cell migration, Circ. Res., 96, 261, 10.1161/01.RES.0000154262.07264.12 · DOI · Paper page
  176. Romero, 2020, Single-Cell RNA Sequencing Analysis Reveals a Crucial Role for CTHRC1 (Collagen Triple Helix Repeat Containing 1) Cardiac Fibroblasts After Myocardial Infarction, Circulation, 142, 1831, 10.1161/CIRCULATIONAHA.119.044557 · DOI · Paper page
  177. McLellan, 2020, High-Resolution Transcriptomic Profiling of the Heart During Chronic Stress Reveals Cellular Drivers of Cardiac Fibrosis and Hypertrophy, Circulation, 142, 1448, 10.1161/CIRCULATIONAHA.119.045115 · DOI · Paper page
  178. Langer, 2021, Molecular imaging of fibroblast activation protein after myocardial infarction using the novel radiotracer [(68)Ga]MHLL1, Theranostics, 11, 7755, 10.7150/thno.51419 · DOI
  179. Shah, 2021, Myocardial Infarction Induces Cardiac Fibroblast Transformation within Injured and Noninjured Regions of the Mouse Heart, J. Proteome Res., 20, 2867, 10.1021/acs.jproteome.1c00098 · DOI
  180. Nagaraju, 2017, Global fibroblast activation throughout the left ventricle but localized fibrosis after myocardial infarction, Sci. Rep., 7, 10801, 10.1038/s41598-017-09790-1 · DOI
  181. Sun, 2000, Cardiac remodeling by fibrous tissue after infarction in rats, J. Lab. Clin. Med., 135, 316, 10.1067/mlc.2000.105971 · DOI · Paper page
  182. Bujak, 2008, Aging-related defects are associated with adverse cardiac remodeling in a mouse model of reperfused myocardial infarction, J. Am. Coll. Cardiol., 51, 1384, 10.1016/j.jacc.2008.01.011 · DOI · Paper page
  183. Frangogiannis, 2014, The inflammatory response in myocardial injury, repair, and remodelling, Nat. Rev. Cardiol., 11, 255, 10.1038/nrcardio.2014.28 · DOI · Paper page
  184. Qian, 2012, In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes, Nature, 485, 593, 10.1038/nature11044 · DOI · Paper page
  185. Song, 2012, Heart repair by reprogramming non-myocytes with cardiac transcription factors, Nature, 485, 599, 10.1038/nature11139 · DOI · Paper page
  186. Keepers, 2020, What’s in a cardiomyocyte—And how do we make one through reprogramming?, Biochim. Biophys. Acta Mol. Cell Res., 1867, 118464, 10.1016/j.bbamcr.2019.03.011 · DOI
  187. Xie, 2022, Direct cardiac reprogramming comes of age: Recent advance and remaining challenges, Semin. Cell Dev. Biol., 122, 37, 10.1016/j.semcdb.2021.07.010 · DOI

Metadata

Authors
Venugopal, H., Hanna, A., Humeres, C., & Frangogiannis, N. G.
Venue
Cells
Publisher
MDPI AG
Published
2022-04-20
Volume
11
Issue
9
Pages
1386
ISSN
2073-4409 (ISSN-L)
OpenAlex
W4224237917
Cited by
248
References
11
FWCI
29.81
Type
journal article
Language
en
Open access
gold
Funders
  • National Institutes of Health (R01 HL76246, R01 HL85440, R01 HL149407)
  • United States Department of Defense (PR181464)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Properties and Functions of Fibroblasts and Myofibroblasts in Myocardial Infarction. https://app.cochat.ai/papers/10.3390/cells11091386
The paper
Venugopal, H., Hanna, A., Humeres, C., & Frangogiannis, N. G. (2022). Properties and Functions of Fibroblasts and Myofibroblasts in Myocardial Infarction. Cells. https://doi.org/10.3390/cells11091386

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.